Syra Health | 8-K: Current report
Syra Health | 8-K: Syra Health Announces First Quarter 2024 Financial Results, Led By Strong Revenue Growth of 47%. Conference call will be held today, Thursday, May 9 at 9:00 am ET
Syra Health | DEFA14A: Others
Syra Health | DEF 14A: Definitive information statements
Syra Health | 8-K: Current report
Syra Health | 8-K: Syra Health Announces Fourth-Quarter and Full-Year 2023 Financial Results. Projects 2024 Revenue Growth of 64% to 100%. Conference call will be held today, Monday, March 25 at 9:00am ET
Syra Health | 8-K: Syra Health Announces Third Quarter 2023 Financial Results Conference call will be held today, Tuesday, November 14 at 9:00am ET
Syra Health | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Syra Health | 8-K: Current report
Syra Health | S-1MEF: A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1
Syra Health | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Syra Health | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Syra Health | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Syra Health | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Syra Health | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Syra Health | S-1: General form for registration of securities under the Securities Act of 1933
No Data